Search

Your search keyword '"Klaschik S"' showing total 82 results

Search Constraints

Start Over You searched for: Author "Klaschik S" Remove constraint Author: "Klaschik S"
82 results on '"Klaschik S"'

Search Results

6. From bench to bar side: Evaluating the red wine storage lesion

14. A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study

16. Influence of Intraoperative Fluid Management on Postoperative Outcome and Mortality of Cytoreductive Surgery for Advanced Ovarian Cancer-A Retrospective Observational Study.

17. [Special features of the perioperative course in patients with frailty syndrome].

18. Pain levels and patient comfort after lower limb arthroplasty comparing i.v. patient-controlled analgesia, continuous peripheral nerve block and neuraxial analgesia: a retrospective cohort analysis of clinical routine data.

19. Comparison of the Newborn Infant Parasympathetic Evaluation (NIPE™) index to changes in heart rate to detect intraoperative nociceptive stimuli in healthy and critically ill children below 2 years: An observational study.

20. Gene expression in the Angiopoietin/TIE axis is altered in peripheral tissue of ovarian cancer patients: A prospective observational study.

22. Perioperative Vascular Biomarker Profiling in Elective Surgery Patients Developing Postoperative Delirium: A Prospective Cohort Study.

23. Risk Factors for Severe Complications in Ovarian Cancer Surgery.

24. 5-HT3 blockade does not attenuate postspinal blood pressure change in cesarean section: A case-control study.

25. Differential modulation of endothelial cell function by fresh frozen plasma.

26. Dynamic changes of angiopoietins and endothelial nitric oxide supply during fluid resuscitation for major gyn-oncological surgery: a prospective observation.

27. Supraglottic devices for airway management in awake craniotomy.

28. Sub-cytotoxic doses of pharmaceutical silica nanoparticles show significant impact on the proteome of HepG2 cells.

29. Network of Mediators for Vascular Inflammation and Leakage Is Dysbalanced during Cytoreductive Surgery for Late-Stage Ovarian Cancer.

30. Synthetic CpG oligonucleotides induce a genetic profile ameliorating murine myocardial I/R injury.

31. Vendor effects on murine gut microbiota influence experimental abdominal sepsis.

32. Pulmonary vascular inflammation: effect of TLR signalling on angiopoietin/TIE regulation.

33. Common carotid artery diameter responds to intravenous volume expansion: an ultrasound observation.

34. The Use of Internal Jugular Vein Ultrasonography to Anticipate Low or High Central Venous Pressure During Mechanical Ventilation.

35. The angiopoietin/TIE receptor system: Focusing its role for ischemia-reperfusion injury.

36. Differentiation between Staphylococcus aureus and coagulase-negative Staphylococcus species by real-time PCR including detection of methicillin resistants in comparison to conventional microbiology testing.

37. Synergistic Stimulation with Different TLR7 Ligands Modulates Gene Expression Patterns in the Human Plasmacytoid Dendritic Cell Line CAL-1.

38. Characterizing the genetic basis of innate immune response in TLR4-activated human monocytes.

39. Anti-atherogenic effects of statins: Impact on angiopoietin-2 release from endothelial cells.

40. Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice.

41. Activation of type I interferon-dependent genes characterizes the "core response" induced by CpG DNA.

42. Rapid qualitative urinary tract infection pathogen identification by SeptiFast real-time PCR.

43. Real-time polymerase chain-reaction detection of pathogens is feasible to supplement the diagnostic sequence for urinary tract infections.

44. FDA guidance on prophylactic DNA vaccines: analysis and recommendations.

45. Short- and long-term changes in gene expression mediated by the activation of TLR9.

46. Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvants.

47. Therapeutic applications and mechanisms underlying the activity of immunosuppressive oligonucleotides.

48. Global changes in gene expression and synergistic interactions induced by TLR9 and TLR3.

49. Inductive and suppressive networks regulate TLR9-dependent gene expression in vivo.

50. CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases.

Catalog

Books, media, physical & digital resources